Nomenclature of HBV core protein-targeting antivirals

Autor:	Fabien Zoulim, Adam Zlotnick, Stephanie Buchholz, Eric Donaldson, John Fry, Anuj Gaggar, Jianming Hu, Michael Kann, Oliver Lenz, Kai Lin, Nagraj Mani, Michael Nassal, William Delaney, Su Wang, Gabriel Westman, Veronica Miller, Harry L. A. Janssen
Přispěvatelé:	Gastroenterology & Hepatology
Rok vydání:	2022
Předmět:	Hepatitis B virus Hepatology SDG 3 - Good Health and Well-being DNA Viral Gastroenterology Humans Virus Replication Antiviral Agents
Zdroj:	Nature Reviews Gastroenterology and Hepatology, 19(12), 748-750. Nature Publishing Group
ISSN:	1759-5053 1759-5045
Popis:	Hepatitis B virus (HBV) core protein-targeting compounds are in or entering clinical development without a standardized nomenclature. We propose a naming convention for these core-targeting antiviral products to provide clarity and accelerate HBV drug development.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48459058d65debbc9e5375a543e47098 https://pubmed.ncbi.nlm.nih.gov/36207612 Zobrazit plný text záznamu Full text from SpringerLink